Pharmaceutical innovation: possibilities and limits of personalised medicine.
In the framework of the German EU Council Presidency, the Federal Ministry of Health and the Federal Institute for Drugs and Medical Devices, an expert conference on Pharmaceutical Innovation - Possibilities and Limits of Personalised Medicine was held in Bonn, on June 11-12, 2007. It was financially supported by the European Commission. The conference aimed to intensify a sustainable networking among the participants and develop robust concepts for the future design of pharmaceutical research and production within the EU. To this end, various stakeholders from the fields of pharmaceutical research, production and licensing were brought together. This publication summarises the main results of the conference. It may reflect the personal views of the individual contributors and is not necessarily the perspective of the Federal Ministry of Health or of the Federal Institute for Drugs and Medical Devices.
D002986:Clinical Trials as Topic; D015195:Drug Design; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D015507:Drugs, Investigational; D005060:Europe; D005858:Germany; D006801:Humans; D009936:Organizational Innovation; D010597:Pharmacogenetics
D015507:Drugs, Investigational